Finlands Akademi
Finansieringsbeslut
 
Namn Casteleijn, Marinus
Organisation HY
Projektets titel Disrupting biotechnology to achieve high quality synthesis for biological drug development
Beslutnr 303884
Beslutsdatum 30.09.2016
Finansieringsperiod 01.10.2016 - 30.09.2018
Finansiering 298 995
WebFOCUS Report
Beskrivning av projektet
Our solution is a modular platform where in one day you can synthesize, add utilities, and test your idea. We introduce to you “In-vitro continuous – protein and conjugation synthesis” or IC-PCS. First we mix the matter of recently living cells with protein building blocks in a bioreactor and add the gene, which holds all information about our protein of interest (POI). Within an hour we can make and purify enough POI for screening via a simple capture step. We wash and add the final formulation. Light treatment releases POI from the surface. Then necessary tools are added, for example to target and enter diseased cells better.